Ribaxamase Uses, Dosage, Side Effects and more
Ribaxamase is under investigation in clinical trial NCT02563106 (A Study of SYN-004 for the Prevention of c.diff in Patients With a LRTI).
| Trade Name | Ribaxamase |
| Generic | Ribaxamase |
| Ribaxamase Other Names | .beta.-lactamase (synthetic bacillus licheniformis isoenzyme syn-004), Ribaxamase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
